UP-024-c07 Uro-oncology late
Intravesical BCG therapy
Treatment interruption or incomplete oncological course
Toxicity, access or pathway deviations may prevent intended treatment and require a revised cancer-control strategy.
This module records catalogue coverage only. Do not use it to make diagnosis or treatment decisions.
Interactive 3D The operation this complication belongs to: Intravesical BCG therapy Interactive BCG instillation model Open the 3D animation 01 Variation coverage
Which versions of the operation this applies to
BCG induction courseBCG maintenance courseRisk-adapted modified BCG pathway
The parent hub contains 3 recorded variations.
The labels above prevent a complication from being implied for an approach where it is not relevant.
02 Evidence
Sources
European Association of Urology EAU Guidelines on Non-muscle-invasive Bladder Cancer
TURBT quality, repeat resection and intravesical-treatment pathways.
Accessed 2026-08-03 · opens source European Association of Urology EAU Guidelines on Urological InfectionsInfection prevention, recognition and procedure-associated infection context.
Accessed 2026-08-03 · opens source British Association of Urological Surgeons Patient information leaflets by procedureUK patient-facing procedure, alternatives, recovery and complication framing.
Accessed 2026-08-03 · opens source03 Same procedure
Other Intravesical BCG complication modules
early BCG cystitis and severe lower-tract symptoms multiple Systemic BCG infection or inflammatory syndrome immediate Traumatic catheterisation with systemic exposure early Urinary bacterial infection late Granulomatous prostatitis, epididymo-orchitis or upper-tract involvement late Bladder contracture or reduced capacity immediate Occupational or household exposure
Return to the complete procedure hub